BIOCRYST SCHEDULED TO PRESENT AT THE CREDIT SUISSE FIRST BOSTON HEALTH CARE CONFERENCE
Birmingham, Alabama - November 11, 2003 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at the Credit Suisse First Boston Health Care Conference in Phoenix on Friday, November 14, 2003, at 11 a.m. local time (1:00 p.m. Eastern Standard Time). Interested investors can listen to the presentation live over the Internet during the conference at the following address: http://www.shareholder.com/biocryst/medialist.cfm
What:
BioCryst Pharmaceuticals, Inc. Presentation at the Credit Suisse First Boston Health Care Conference
When:
Friday, November 14, 2003, at 1:00 p.m. EST
Where:
http://www.shareholder.com/biocryst/medialist.cfm
How:
Live over the Internet -- Simply log on to the web at the address above
For those unable to listen at the designated time, the webcast will remain available for replay on http://www.shareholder.com/biocryst/medialist.cfm for 30 days following the conference.
Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.